Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.769335
Title: Contribution of glucose to increased respiratory bacterial burden in hyperglycaemia
Author: Gill, Simren Kaur
ISNI:       0000 0004 7657 1790
Awarding Body: Imperial College London
Current Institution: Imperial College London
Date of Award: 2017
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
It has recently been proposed that uncontrolled hyperglycaemia in people with diabetes increases lung glucose, so providing a richer growth medium facilitating bacterial infection. Where diabetes is controlled, there is a reduced associated risk of bacterial infection. The aim of this thesis was to determine the effect of glucose on bacterial growth in vivo and directly link bacterial glucose metabolism with increased respiratory tract bacterial load in hyperglycaemia. P. aeruginosa, a Gram-negative opportunistic pathogen, which is a major cause of respiratory infections, was used as chronic P. aeruginosa infections are most commonly associated with people with cystic fibrosis (CF) and chronic obstructive pulmonary diseases (COPD), but importantly P. aeruginosa is increasingly diagnosed in diabetic patients with pneumonia/lung infection. To test the hypothesis, P. aeruginosa mutants were generated by deleting oprB, gltK, gtrS and glk genes and these mutant strains were used in in vitro and in vivo infection models developed during this thesis. The mutants had drastically reduced growth in minimal medium containing glucose as the sole carbon source, whereas they were unaltered when grown in rich medium. In order to explore the effect of elevated glucose with minimal effects on the immune response, streptozocin was used to induce diabetes, instead of genetically obese mice, which have a complex phenotype and impaired immune responses. Streptozocin induced hyperglycaemia also led to increased bacterial load in the airways when mice were infected with wild type PAO1 but not with the glucose uptake and metabolism mutants. To further support this hypothesis when metformin was used to lower glucose levels it resulted in a reduced bacterial burden.
Supervisor: Tregoning, John ; Filloux, Alain Sponsor: Wellcome Trust
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.769335  DOI:
Share: